Company / Capital Returned to Shareholders
Royalty Pharma plc Capital Returned to Shareholders History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$1.2B
FY2025
5-year range
$4.3M / $1.2B
FY2021-FY2025
Trend
+434.5%
vs FY2024
Sector context
#10 of 52
Health Care
What the data says
Capital Returned to Shareholders changed +434% YoY in FY2025, a notable deviation from the 4-year average annual change of +1838%.
Based on SEC 10-K filings.
$1.2B in FY2025. Top quartile in the Health Care sector.
Improved from $305M to $1.2B over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 52This company $1.2B Sector average $1.3B
▼
-8.0% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 434.5% year-over-year.
- Ranks #10 out of 52 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +434.5% |
| FY2024 | $229.7M | -24.6% |
| FY2023 | $304.8M | - |
| FY2022 | - | - |
| FY2021 | $4.3M | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $4.3M | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026